A bold new bill to allow AI chatbots to prescribe controlled drugs has been introduced into the House for review.

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

Wen Shuhao, Xtalpi's cofounder and chairman, speaks at the company's IPO ceremony in Hong Kong on June 13, 2024. Shanshan Kao/Forbes Asia ByZinnia Lee, Forbes Staff. I cover successful ...

Jim Cramer, the host of Mad Money, discussed the upcoming market and corporate activity to look forward to this week, which ...

SNIFF, a new robotic detection dog, can enhance airport security with its advanced sensor technology and tireless vigilance.

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google DeepMind CEO Demis Hassabis suggested Tuesday. Speaking on a panel at the World ...

Coverage of obesity drugs in health plans and the rapid adoption of artificial intelligence are two areas of change that health plans will face during the coming year. A panel of Avalere experts ...

AI for accelerated antibody discovery Traditionally ... where such platforms are affecting the status quo and transforming the way we discover drugs. Vertex's gene-editing therapy for sickle ...